Brief: Regulus Therapeutics Announces Appointment Of Preston Klassen, M.D. To Its Board Of Directors
23/06/2023 13:03
June 23 (Reuters) - Regulus Therapeutics Inc RGLS.O :
* REGULUS THERAPEUTICS ANNOUNCES APPOINTMENT OF PRESTON S.
KLASSEN, M.D. TO ITS BOARD OF DIRECTORS
Source text for Eikon: ID:nPn67fTVCa
Further company coverage: RGLS.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Regulus Therapeutics
See all newsBrief: Novartis Completes Acquisition Of Regulus Therapeutics
Brief: Novartis Announces Expiration Of Hart-Scott-Rodino Waiting Period Of Regulus Therapeutics Tender Offer
Brief: Novartis Announces Commencement Of Tender Offer To Acquire Regulus Therapeutics
Regulus Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Regulus Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview